neutral
Recently
Perspective Therapeutics meets EPS estimates with revenue beat
Perspective Therapeutics matched EPS expectations while surpassing revenue estimates, with market reaction delayed due to the US holiday closure.
Perspective Therapeutics reported fourth-quarter earnings showing an EPS loss of 0.29, matching market expectations. Revenue reached $290,000, exceeding the forecast of $185,860. The radiopharmaceutical developer continued advancing its clinical pipeline during the quarter. With US markets closed for Christmas, investor response to the results is expected to materialize once trading resumes.